A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients

INTRODUCTION: Increased left ventricular mass index (LVMI) is associated with mortality in end-stage renal disease. LVMI regression may improve outcomes. Allopurinol has reduced LVMI in randomized controlled trials in chronic kidney disease, diabetes, and ischemic heart disease. This study investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutherford, Elaine, Ireland, Sheila, Mangion, Kenneth, Stewart, Graham A., MacGregor, Mark S., Roditi, Giles, Woodward, Rosemary, Gandy, Stephen J., Houston, J. Graeme, Jardine, Alan G., Rauchhaus, Petra, Witham, Miles D., Mark, Patrick B., Struthers, Allan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783562/
https://www.ncbi.nlm.nih.gov/pubmed/33426394
http://dx.doi.org/10.1016/j.ekir.2020.10.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783562/
https://www.ncbi.nlm.nih.gov/pubmed/33426394
http://dx.doi.org/10.1016/j.ekir.2020.10.025

Ejemplares similares